Mechanisms associated with IL-6–induced up-regulation of Jak3 and its role in monocytic differentiation
James K. Mangan(UC San Diego Health System), E. Premkumar Reddy(The Graduate Center, CUNY), Sushil G. Rane(National Institute of Diabetes and Digestive and Kidney Diseases), Anthony D. Kang(Beth Israel Deaconess Medical Center), Brian Wong(NewYork–Presbyterian Brooklyn Methodist Hospital), Arshad Amanullah(Temple University)
Cited by 29
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2019|274
Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey
|BMC Cancer|2016|194
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|192